DNA can exist in a variety of noncanonical structures in addition to Watson-Crick double-stranded helix. It has been known since the 1960s that DNA sequences with high guanine content can fold into a helical structure, composed of stacked G-tetrads, termed G-quadruplex (G4) [1] . Each G-tetrad is a stable arrangement of four guanines connected via Hoogsteen hydrogen bonding. Biological G4s are typically thought to be monomolecular structures formed by stacks of two to four G-tetrads further stabilized by a monovalent cation (often K + ), which binds in a central cavity between each pair of G-tetrads.
While in vitro formation of G4s has been clearly demonstrated, their existence and functional roles in biological systems are a matter of intense investigation [2] . Overall, there is emerging evidence for G4 roles in the regulation of gene expression and in DNA replication and repair. Some evidence for biological G4 formation has come from studies employing anti-G4 antibodies, most prominently the BG4 single-chain antibody fragment, which binds G4 DNA and RNA structures with apparently high selectivity in vitro [3] . BG4 preferentially immunoprecipitates chromatin regions with high quadruplex-forming potential (QFP), and BG4 staining of replicating chromatin is enhanced by the deletion of DNA helicases that unwind G4 DNA, thus providing some evidence that BG4 can recognize G4s in vivo [4, 5] . However, there is little information about the extent to which BG4 might bind to cross-reactive targets in biological samples, or even induce and stabilize G4 folds that do not exist naturally. Thus, BG4 staining of fixed cells should, by itself, be considered provisional evidence of G4s in vivo.
A report by Toshniwal et al. describes for the first time possible connections between G4 structures and scar formation, identifying G4s as potential therapeutic targets in wound healing [6] . In mammals, injury caused by chemical, physical, or biological stress is followed by repair processes that typically employ a balance between regeneration versus replacement of the original tissue with a fibrotic scar. Medical interventions aim to promote regeneration and minimize scarring, as extensive scarring (fibrosis) can compromise tissue architecture and organ function. A key player in wound repair is transforming growth factor beta (TGF-b), a multifunctional cytokine signaling protein. Activation of TGF-b in the extracellular matrix can drive expression within fibroblasts of connective tissue growth factor and collagen 1, which contribute to fibrosis.
Toshniwal et al. investigated a link between G4 formation and collagen expression (both at protein and mRNA levels) in response to TGF-b treatment of human primary fibroblasts cultured under scar-forming conditions. TGF-b led to a local increase in collagen expression accompanied by an increase in nuclear BG4 staining, suggesting a possible increase in G4 levels. As expected, treatment with the TGF-b inhibitor, PXS64, blocked collagen expression and BG4 staining. Furthermore, TGF-b is known to elevate intracellular Ca 2+ levels, and treatment with thapsigargin, a small-molecule inhibitor of Ca 2+ -ATPase, leads to a comparable decrease in Ca 2+ and G4 levels. Given reports that some G4s can be stabilized by Ca 2+ [7] , the authors raised the possibility that increased intracellular Ca 2+ might promote G4 formation more directly, and it would be interesting to test this experimentally both in vitro and in vivo. Also of note, TGF-b is known to cause cell cycle arrest at the G1/S boundary, a point where nuclear BG4 staining was reported to increase [3] , and so it will be important to test whether the elevation in apparent G4s is related to this arrest [8] .
The authors identified three high QFP sequences in the transcriptional promoter region of COL1A1, which encodes collagen 1. These formed robust G4 structures in vitro under physiological pH and ionic conditions, suggesting the possibility of in vivo existence of these G4s. Treatment of the QFP sequences in vitro with one equivalent of the G4-stabilizing small-molecule ligand, GQC-05 [9] , led to the stabilization of G4s by 7-9°C. Supporting a role for G4s in fibrosis, treatment of human primary fibroblasts (unstimulated by TGF-b) with GQC-05 led to increased levels of BG4 foci and collagen expression. It will be interesting to test whether the COL1A1 QFP sequences are involved in this regulation.
Toshniwal et al. findings suggest unanticipated links between G4s and scar formation [6] . It will be exciting to probe the underlying mechanisms further, and to test the extent to which G4s can be targeted for therapeutic intervention to improve wound healing.
